Figure 3From: Stereotactic body radiotherapy for organ-confined prostate cancer Median PSA levels (ng/ml +/- 1 standard deviation) for patients who did not receive ADT and who have a minimum follow-up of 12 month in the (A) 35 Gy dose level and (B) 36.25 Gy dose level.Back to article page